Literature DB >> 6087620

Synergistic interaction of corticotropin releasing factor and arginine vasopressin on adrenocorticotropin and cortisol secretion in Macaca fuscata.

K Hashimoto, K Murakami, T Hattori, Z Ota.   

Abstract

Plasma immunoreactive CRF measured by radioimmunoassay decreased rapidly after intravenous injection of synthetic ovine corticotropin releasing factor (CRF) and showed a bi-exponential decay curve in five macaca fuscatas. Half lives of plasma immunoreactive CRF were 5.8 +/- 1.4 (Mean +/- SEM) min for the fast component and 38.3 +/- 2.4 min for the slow component. A bolus injection of 5 micrograms/kg CRF significantly increased the plasma cortisol level. CRF at 5 micrograms/kg induced a delayed response of ACTH and cortisol. Arginine vasopressin (AVP) at 0.5 micrograms/kg induced a slight increase in plasma ACTH and cortisol, but AVP at 0.1 micrograms/kg evoked no significant increase. When 0.5 micrograms/kg CRF and 0.1 micrograms/kg AVP were administered simultaneously, significant ACTH and cortisol responses occurred. The results indicate that CRF and AVP act synergistically to stimulate ACTH secretion in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087620     DOI: 10.18926/AMO/30349

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  2 in total

1.  Exaggerated sympathetic mediated responses to behavioral or pharmacological challenges following antenatal betamethasone exposure.

Authors:  Hossam A Shaltout; Mark C Chappell; James C Rose; Debra I Diz
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-03-08       Impact factor: 4.310

2.  Human corticotropin-releasing factor plus lysine vasopressin test during glucocorticoid therapy.

Authors:  K Hashimoto; S Suemaru; T Takao; M Sugawara; T Hattori; J Kageyama; K Takahashi; Z Ota
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.